nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—RRM2—uterine cancer	0.596	1	CbGaD
Clofarabine—ABCG2—Dactinomycin—uterine cancer	0.0646	0.381	CbGbCtD
Clofarabine—ABCG2—Carboplatin—uterine cancer	0.0434	0.256	CbGbCtD
Clofarabine—ABCG2—Etoposide—uterine cancer	0.0365	0.215	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—uterine cancer	0.0249	0.147	CbGbCtD
Clofarabine—RRM1—Nucleotide Metabolism—POLD1—uterine cancer	0.00319	0.0486	CbGpPWpGaD
Clofarabine—RRM1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00278	0.0423	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide Metabolism—RRM2—uterine cancer	0.00266	0.0405	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide Metabolism—POLD1—uterine cancer	0.00263	0.0401	CbGpPWpGaD
Clofarabine—Cytarabine—POLD1—uterine cancer	0.0024	0.732	CrCbGaD
Clofarabine—POLA1—Removal of the Flap Intermediate—POLD1—uterine cancer	0.0023	0.035	CbGpPWpGaD
Clofarabine—POLA1—Leading Strand Synthesis—POLD1—uterine cancer	0.0023	0.035	CbGpPWpGaD
Clofarabine—POLA1—myometrium—uterine cancer	0.0022	0.0405	CbGeAlD
Clofarabine—RRM2—myometrium—uterine cancer	0.0021	0.0387	CbGeAlD
Clofarabine—POLA1—Processive synthesis on the lagging strand—POLD1—uterine cancer	0.00206	0.0314	CbGpPWpGaD
Clofarabine—POLA1—Nucleotide Metabolism—POLD1—uterine cancer	0.0018	0.0274	CbGpPWpGaD
Clofarabine—RRM1—myometrium—uterine cancer	0.00175	0.0322	CbGeAlD
Clofarabine—POLA1—uterine cervix—uterine cancer	0.00171	0.0315	CbGeAlD
Clofarabine—RRM1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00171	0.0261	CbGpPWpGaD
Clofarabine—POLA1—Lagging Strand Synthesis—POLD1—uterine cancer	0.00166	0.0253	CbGpPWpGaD
Clofarabine—POLA1—G1/S-Specific Transcription—RRM2—uterine cancer	0.00164	0.025	CbGpPWpGaD
Clofarabine—RRM2—uterine cervix—uterine cancer	0.00164	0.0301	CbGeAlD
Clofarabine—POLA1—decidua—uterine cancer	0.00163	0.03	CbGeAlD
Clofarabine—RRM2—decidua—uterine cancer	0.00156	0.0287	CbGeAlD
Clofarabine—POLA1—endometrium—uterine cancer	0.00155	0.0285	CbGeAlD
Clofarabine—POLA1—Telomere C-strand (Lagging Strand) Synthesis—POLD1—uterine cancer	0.00154	0.0235	CbGpPWpGaD
Clofarabine—RRM2—renal system—uterine cancer	0.00153	0.0282	CbGeAlD
Clofarabine—POLA1—mammalian vulva—uterine cancer	0.0015	0.0276	CbGeAlD
Clofarabine—POLA1—Nucleotide Metabolism—RRM2—uterine cancer	0.0015	0.0228	CbGpPWpGaD
Clofarabine—RRM2—endometrium—uterine cancer	0.00148	0.0272	CbGeAlD
Clofarabine—RRM2—mammalian vulva—uterine cancer	0.00143	0.0264	CbGeAlD
Clofarabine—RRM2—uterus—uterine cancer	0.00137	0.0251	CbGeAlD
Clofarabine—RRM1—uterine cervix—uterine cancer	0.00136	0.025	CbGeAlD
Clofarabine—DCK—myometrium—uterine cancer	0.00136	0.025	CbGeAlD
Clofarabine—RRM1—smooth muscle tissue—uterine cancer	0.00132	0.0243	CbGeAlD
Clofarabine—RRM1—decidua—uterine cancer	0.0013	0.0238	CbGeAlD
Clofarabine—POLA1—Extension of Telomeres—POLD1—uterine cancer	0.00128	0.0195	CbGpPWpGaD
Clofarabine—RRM1—renal system—uterine cancer	0.00127	0.0234	CbGeAlD
Clofarabine—RRM1—endometrium—uterine cancer	0.00123	0.0226	CbGeAlD
Clofarabine—RRM2—female reproductive system—uterine cancer	0.00123	0.0226	CbGeAlD
Clofarabine—RRM1—mammalian vulva—uterine cancer	0.00119	0.0219	CbGeAlD
Clofarabine—POLA1—DNA strand elongation—POLD1—uterine cancer	0.00118	0.0181	CbGpPWpGaD
Clofarabine—POLA1—female gonad—uterine cancer	0.00117	0.0215	CbGeAlD
Clofarabine—POLA1—vagina—uterine cancer	0.00116	0.0214	CbGeAlD
Clofarabine—RRM1—uterus—uterine cancer	0.00113	0.0209	CbGeAlD
Clofarabine—RRM2—female gonad—uterine cancer	0.00112	0.0205	CbGeAlD
Clofarabine—RRM2—vagina—uterine cancer	0.00111	0.0204	CbGeAlD
Clofarabine—DCK—uterine cervix—uterine cancer	0.00106	0.0194	CbGeAlD
Clofarabine—RRM1—female reproductive system—uterine cancer	0.00102	0.0187	CbGeAlD
Clofarabine—DCK—decidua—uterine cancer	0.00101	0.0185	CbGeAlD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—RRM2—uterine cancer	0.000964	0.0147	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.000957	0.0146	CbGpPWpGaD
Clofarabine—DCK—endometrium—uterine cancer	0.000956	0.0176	CbGeAlD
Clofarabine—POLA1—DNA Replication—POLD1—uterine cancer	0.000953	0.0145	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000937	0.0143	CbGpPWpGaD
Clofarabine—RRM1—female gonad—uterine cancer	0.000928	0.0171	CbGeAlD
Clofarabine—DCK—mammalian vulva—uterine cancer	0.000925	0.017	CbGeAlD
Clofarabine—RRM1—vagina—uterine cancer	0.000922	0.017	CbGeAlD
Clofarabine—RRM1—E2F transcription factor network—RRM2—uterine cancer	0.000907	0.0138	CbGpPWpGaD
Clofarabine—DCK—uterus—uterine cancer	0.000881	0.0162	CbGeAlD
Clofarabine—Cladribine—RRM2—uterine cancer	0.000878	0.268	CrCbGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000865	0.0132	CbGpPWpGaD
Clofarabine—RRM1—Nucleotide metabolism—RRM2—uterine cancer	0.00086	0.0131	CbGpPWpGaD
Clofarabine—POLA1—Norethindrone—Progesterone—uterine cancer	0.000845	0.332	CbGdCrCtD
Clofarabine—DCK—female reproductive system—uterine cancer	0.000792	0.0146	CbGeAlD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.000788	0.012	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.000788	0.012	CbGpPWpGaD
Clofarabine—ABCG2—myometrium—uterine cancer	0.000758	0.0139	CbGeAlD
Clofarabine—POLA1—lymph node—uterine cancer	0.000751	0.0138	CbGeAlD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.000736	0.0112	CbGpPWpGaD
Clofarabine—DCK—female gonad—uterine cancer	0.000721	0.0133	CbGeAlD
Clofarabine—RRM2—lymph node—uterine cancer	0.000718	0.0132	CbGeAlD
Clofarabine—DCK—vagina—uterine cancer	0.000716	0.0132	CbGeAlD
Clofarabine—RRM2—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000712	0.0109	CbGpPWpGaD
Clofarabine—POLA1—Levonorgestrel—Progesterone—uterine cancer	0.000672	0.264	CbGdCrCtD
Clofarabine—DCK—Nucleotide metabolism—RRM2—uterine cancer	0.000662	0.0101	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.000606	0.00924	CbGpPWpGaD
Clofarabine—RRM1—lymph node—uterine cancer	0.000596	0.011	CbGeAlD
Clofarabine—ABCG2—uterine cervix—uterine cancer	0.00059	0.0108	CbGeAlD
Clofarabine—POLA1—Telomere Maintenance—POLD1—uterine cancer	0.000581	0.00885	CbGpPWpGaD
Clofarabine—ABCG2—decidua—uterine cancer	0.000562	0.0103	CbGeAlD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MSH6—uterine cancer	0.000539	0.00821	CbGpPWpGaD
Clofarabine—ABCG2—endometrium—uterine cancer	0.000533	0.00981	CbGeAlD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000528	0.00804	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—RRM2—uterine cancer	0.000527	0.00803	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000523	0.00797	CbGpPWpGaD
Clofarabine—ABCG2—mammalian vulva—uterine cancer	0.000516	0.00949	CbGeAlD
Clofarabine—POLA1—E2F transcription factor network—RRM2—uterine cancer	0.000511	0.00778	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—POLD1—uterine cancer	0.000492	0.0075	CbGpPWpGaD
Clofarabine—ABCG2—uterus—uterine cancer	0.000491	0.00904	CbGeAlD
Clofarabine—POLA1—Chromosome Maintenance—POLD1—uterine cancer	0.000484	0.00737	CbGpPWpGaD
Clofarabine—DCK—lymph node—uterine cancer	0.000463	0.00852	CbGeAlD
Clofarabine—POLA1—DNA Replication—POLD1—uterine cancer	0.000461	0.00703	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM2—uterine cancer	0.000444	0.00676	CbGpPWpGaD
Clofarabine—POLA1—S Phase—POLD1—uterine cancer	0.000404	0.00615	CbGpPWpGaD
Clofarabine—ABCG2—female gonad—uterine cancer	0.000402	0.00739	CbGeAlD
Clofarabine—ABCG2—vagina—uterine cancer	0.0004	0.00735	CbGeAlD
Clofarabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.000392	0.154	CbGdCrCtD
Clofarabine—POLA1—G1/S Transition—RRM2—uterine cancer	0.000371	0.00565	CbGpPWpGaD
Clofarabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.000363	0.142	CbGdCrCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000336	0.00512	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—uterine cancer	0.000328	0.00501	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN2A—uterine cancer	0.000313	0.00477	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—RRM2—uterine cancer	0.000312	0.00476	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000311	0.00474	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MLH3—uterine cancer	0.000302	0.0046	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000295	0.00449	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000283	0.00431	CbGpPWpGaD
Clofarabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.000277	0.109	CbGdCrCtD
Clofarabine—RRM1—E2F transcription factor network—CDKN1B—uterine cancer	0.000277	0.00422	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000275	0.0042	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—uterine cancer	0.000271	0.00412	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000266	0.00406	CbGpPWpGaD
Clofarabine—ABCG2—lymph node—uterine cancer	0.000258	0.00475	CbGeAlD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—uterine cancer	0.000258	0.00392	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000253	0.00386	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—EP300—uterine cancer	0.000243	0.00371	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000241	0.00367	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000236	0.0036	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN1B—uterine cancer	0.000228	0.00348	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—NDC80—uterine cancer	0.000216	0.00329	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—NDC80—uterine cancer	0.000211	0.00322	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MLH3—uterine cancer	0.000207	0.00315	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000201	0.00306	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—EP300—uterine cancer	0.0002	0.00305	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000198	0.00302	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000189	0.00288	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000189	0.00288	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—uterine cancer	0.000188	0.00287	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000185	0.00282	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—POLD1—uterine cancer	0.00018	0.00274	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—uterine cancer	0.000176	0.00268	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000175	0.00267	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000167	0.00254	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—CDKN1B—uterine cancer	0.000166	0.00252	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NDUFB11—uterine cancer	0.000165	0.00252	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SRD5A2—uterine cancer	0.000165	0.00252	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—NDC80—uterine cancer	0.000162	0.00246	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000159	0.00243	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000157	0.0024	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN1B—uterine cancer	0.000156	0.00238	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000151	0.0023	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—NDC80—uterine cancer	0.000144	0.0022	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000143	0.00217	CbGpPWpGaD
Clofarabine—Anorexia—Dactinomycin—uterine cancer	0.00014	0.00129	CcSEcCtD
Clofarabine—Neoplasm—Doxorubicin—uterine cancer	0.00014	0.00129	CcSEcCtD
Clofarabine—Mouth ulceration—Doxorubicin—uterine cancer	0.00014	0.00129	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	0.000139	0.00213	CbGpPWpGaD
Clofarabine—Flushing—Etoposide—uterine cancer	0.000139	0.00128	CcSEcCtD
Clofarabine—Cardiac disorder—Etoposide—uterine cancer	0.000139	0.00128	CcSEcCtD
Clofarabine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00128	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000139	0.00211	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—EP300—uterine cancer	0.000138	0.0021	CbGpPWpGaD
Clofarabine—Pulmonary oedema—Doxorubicin—uterine cancer	0.000137	0.00127	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—POLD1—uterine cancer	0.000137	0.00209	CbGpPWpGaD
Clofarabine—Dizziness—Progesterone—uterine cancer	0.000137	0.00127	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—EP300—uterine cancer	0.000137	0.00209	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NDUFB11—uterine cancer	0.000136	0.00207	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SRD5A2—uterine cancer	0.000136	0.00207	CbGpPWpGaD
Clofarabine—Angiopathy—Etoposide—uterine cancer	0.000136	0.00125	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—uterine cancer	0.000136	0.00207	CbGpPWpGaD
Clofarabine—Immune system disorder—Etoposide—uterine cancer	0.000135	0.00125	CcSEcCtD
Clofarabine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000135	0.00125	CcSEcCtD
Clofarabine—Mediastinal disorder—Etoposide—uterine cancer	0.000135	0.00124	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—YWHAE—uterine cancer	0.000134	0.00205	CbGpPWpGaD
Clofarabine—Chills—Etoposide—uterine cancer	0.000134	0.00124	CcSEcCtD
Clofarabine—Sepsis—Doxorubicin—uterine cancer	0.000134	0.00124	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000134	0.00123	CcSEcCtD
Clofarabine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.00123	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MLH1—uterine cancer	0.000133	0.00203	CbGpPWpGaD
Clofarabine—Alopecia—Etoposide—uterine cancer	0.000132	0.00122	CcSEcCtD
Clofarabine—Vomiting—Progesterone—uterine cancer	0.000132	0.00122	CcSEcCtD
Clofarabine—Renal failure acute—Epirubicin—uterine cancer	0.000131	0.00121	CcSEcCtD
Clofarabine—Rash—Progesterone—uterine cancer	0.000131	0.00121	CcSEcCtD
Clofarabine—Dermatitis—Progesterone—uterine cancer	0.000131	0.00121	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—uterine cancer	0.000131	0.00199	CbGpPWpGaD
Clofarabine—Headache—Progesterone—uterine cancer	0.00013	0.0012	CcSEcCtD
Clofarabine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.00119	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000128	0.00196	CbGpPWpGaD
Clofarabine—Decreased appetite—Dactinomycin—uterine cancer	0.000128	0.00118	CcSEcCtD
Clofarabine—DCK—Metabolism—NDUFB11—uterine cancer	0.000127	0.00194	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SRD5A2—uterine cancer	0.000127	0.00194	CbGpPWpGaD
Clofarabine—Fatigue—Dactinomycin—uterine cancer	0.000127	0.00117	CcSEcCtD
Clofarabine—Back pain—Etoposide—uterine cancer	0.000126	0.00116	CcSEcCtD
Clofarabine—Pain—Dactinomycin—uterine cancer	0.000125	0.00116	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—uterine cancer	0.000125	0.00191	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000125	0.0019	CbGpPWpGaD
Clofarabine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000124	0.00115	CcSEcCtD
Clofarabine—Lethargy—Epirubicin—uterine cancer	0.000124	0.00114	CcSEcCtD
Clofarabine—Nausea—Progesterone—uterine cancer	0.000123	0.00114	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—POLD1—uterine cancer	0.000123	0.00187	CbGpPWpGaD
Clofarabine—Renal failure acute—Doxorubicin—uterine cancer	0.000121	0.00112	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000121	0.00185	CbGpPWpGaD
Clofarabine—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000121	0.00112	CcSEcCtD
Clofarabine—Pain in extremity—Epirubicin—uterine cancer	0.000121	0.00112	CcSEcCtD
Clofarabine—Feeling abnormal—Dactinomycin—uterine cancer	0.000121	0.00112	CcSEcCtD
Clofarabine—Anaemia—Etoposide—uterine cancer	0.00012	0.00111	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—YWHAE—uterine cancer	0.00012	0.00183	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00012	0.00111	CcSEcCtD
Clofarabine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.0011	CcSEcCtD
Clofarabine—RRM1—Metabolism—AKR1B1—uterine cancer	0.000119	0.00182	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—STAR—uterine cancer	0.000119	0.00182	CbGpPWpGaD
Clofarabine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000119	0.00109	CcSEcCtD
Clofarabine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000119	0.00109	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000118	0.0018	CbGpPWpGaD
Clofarabine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000118	0.00109	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1B—uterine cancer	0.000118	0.00179	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.000117	0.00179	CbGpPWpGaD
Clofarabine—Leukopenia—Etoposide—uterine cancer	0.000116	0.00108	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	0.000116	0.00177	CbGpPWpGaD
Clofarabine—Abdominal pain—Dactinomycin—uterine cancer	0.000116	0.00107	CcSEcCtD
Clofarabine—Body temperature increased—Dactinomycin—uterine cancer	0.000116	0.00107	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—RRM2—uterine cancer	0.000115	0.00174	CbGpPWpGaD
Clofarabine—Lethargy—Doxorubicin—uterine cancer	0.000114	0.00106	CcSEcCtD
Clofarabine—Cough—Etoposide—uterine cancer	0.000114	0.00105	CcSEcCtD
Clofarabine—Blood creatinine increased—Epirubicin—uterine cancer	0.000113	0.00105	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1B—uterine cancer	0.000113	0.00172	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000113	0.00172	CbGpPWpGaD
Clofarabine—Dehydration—Epirubicin—uterine cancer	0.000113	0.00104	CcSEcCtD
Clofarabine—Hypertension—Etoposide—uterine cancer	0.000112	0.00104	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000112	0.00103	CcSEcCtD
Clofarabine—Pain in extremity—Doxorubicin—uterine cancer	0.000112	0.00103	CcSEcCtD
Clofarabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000112	0.00103	CcSEcCtD
Clofarabine—Dry skin—Epirubicin—uterine cancer	0.000111	0.00102	CcSEcCtD
Clofarabine—Abdominal pain upper—Epirubicin—uterine cancer	0.000111	0.00102	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00011	0.00102	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000109	0.00101	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000109	0.00101	CcSEcCtD
Clofarabine—Hypersensitivity—Dactinomycin—uterine cancer	0.000108	0.000998	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	0.000108	0.00164	CbGpPWpGaD
Clofarabine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000107	0.000986	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000107	0.00163	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000106	0.00162	CbGpPWpGaD
Clofarabine—Infection—Etoposide—uterine cancer	0.000106	0.000974	CcSEcCtD
Clofarabine—Asthenia—Dactinomycin—uterine cancer	0.000105	0.000972	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000105	0.000969	CcSEcCtD
Clofarabine—Influenza—Epirubicin—uterine cancer	0.000105	0.000966	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—uterine cancer	0.000104	0.000962	CcSEcCtD
Clofarabine—Thrombocytopenia—Etoposide—uterine cancer	0.000104	0.00096	CcSEcCtD
Clofarabine—Tachycardia—Etoposide—uterine cancer	0.000104	0.000957	CcSEcCtD
Clofarabine—Skin disorder—Etoposide—uterine cancer	0.000103	0.000952	CcSEcCtD
Clofarabine—POLA1—S Phase—CDKN1B—uterine cancer	0.000103	0.00157	CbGpPWpGaD
Clofarabine—Dry skin—Doxorubicin—uterine cancer	0.000103	0.000948	CcSEcCtD
Clofarabine—Hyperhidrosis—Etoposide—uterine cancer	0.000103	0.000948	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—uterine cancer	0.000103	0.000947	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RRM2—uterine cancer	0.000102	0.00156	CbGpPWpGaD
Clofarabine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000102	0.000945	CcSEcCtD
Clofarabine—Anorexia—Etoposide—uterine cancer	0.000101	0.000935	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	0.000101	0.00154	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	0.000101	0.00154	CbGpPWpGaD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000101	0.000932	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000101	0.000932	CcSEcCtD
Clofarabine—Diarrhoea—Dactinomycin—uterine cancer	0.0001	0.000927	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—uterine cancer	9.94e-05	0.000918	CcSEcCtD
Clofarabine—Hypotension—Etoposide—uterine cancer	9.92e-05	0.000916	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	9.89e-05	0.000912	CcSEcCtD
Clofarabine—RRM2—Metabolism—STAR—uterine cancer	9.83e-05	0.0015	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKR1B1—uterine cancer	9.83e-05	0.0015	CbGpPWpGaD
Clofarabine—Neutropenia—Epirubicin—uterine cancer	9.79e-05	0.000904	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—uterine cancer	9.73e-05	0.000898	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—uterine cancer	9.69e-05	0.000894	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	9.54e-05	0.00145	CbGpPWpGaD
Clofarabine—Paraesthesia—Etoposide—uterine cancer	9.54e-05	0.00088	CcSEcCtD
Clofarabine—Pancreatitis—Doxorubicin—uterine cancer	9.5e-05	0.000877	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—uterine cancer	9.47e-05	0.000874	CcSEcCtD
Clofarabine—Dyspnoea—Etoposide—uterine cancer	9.47e-05	0.000874	CcSEcCtD
Clofarabine—Somnolence—Etoposide—uterine cancer	9.44e-05	0.000872	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—uterine cancer	9.39e-05	0.000867	CcSEcCtD
Clofarabine—RRM1—Metabolism—POLD1—uterine cancer	9.37e-05	0.00143	CbGpPWpGaD
Clofarabine—Infestation NOS—Epirubicin—uterine cancer	9.34e-05	0.000862	CcSEcCtD
Clofarabine—Infestation—Epirubicin—uterine cancer	9.34e-05	0.000862	CcSEcCtD
Clofarabine—Vomiting—Dactinomycin—uterine cancer	9.33e-05	0.000861	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	9.25e-05	0.000854	CcSEcCtD
Clofarabine—Rash—Dactinomycin—uterine cancer	9.25e-05	0.000854	CcSEcCtD
Clofarabine—Decreased appetite—Etoposide—uterine cancer	9.23e-05	0.000852	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—uterine cancer	9.2e-05	0.000849	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—YWHAE—uterine cancer	9.2e-05	0.0014	CbGpPWpGaD
Clofarabine—DCK—Metabolism—STAR—uterine cancer	9.19e-05	0.0014	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKR1B1—uterine cancer	9.19e-05	0.0014	CbGpPWpGaD
Clofarabine—Renal failure—Epirubicin—uterine cancer	9.18e-05	0.000847	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Etoposide—uterine cancer	9.17e-05	0.000846	CcSEcCtD
Clofarabine—Fatigue—Etoposide—uterine cancer	9.16e-05	0.000845	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—uterine cancer	9.15e-05	0.000845	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—uterine cancer	9.1e-05	0.00084	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—uterine cancer	9.1e-05	0.00084	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MLH1—uterine cancer	9.09e-05	0.00139	CbGpPWpGaD
Clofarabine—Pain—Etoposide—uterine cancer	9.08e-05	0.000838	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.07e-05	0.00138	CbGpPWpGaD
Clofarabine—Neutropenia—Doxorubicin—uterine cancer	9.06e-05	0.000836	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2B—uterine cancer	9.03e-05	0.00138	CbGpPWpGaD
Clofarabine—Upper respiratory tract infection—Doxorubicin—uterine cancer	9e-05	0.000831	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—uterine cancer	8.9e-05	0.000822	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—uterine cancer	8.83e-05	0.000815	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—uterine cancer	8.8e-05	0.000813	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—uterine cancer	8.76e-05	0.000809	CcSEcCtD
Clofarabine—RRM1—Metabolism—AKR1C1—uterine cancer	8.76e-05	0.00134	CbGpPWpGaD
Clofarabine—Sinusitis—Epirubicin—uterine cancer	8.76e-05	0.000808	CcSEcCtD
Clofarabine—Feeling abnormal—Etoposide—uterine cancer	8.75e-05	0.000808	CcSEcCtD
Clofarabine—Nausea—Dactinomycin—uterine cancer	8.72e-05	0.000805	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—BIRC5—uterine cancer	8.72e-05	0.00133	CbGpPWpGaD
Clofarabine—Pneumonia—Doxorubicin—uterine cancer	8.69e-05	0.000802	CcSEcCtD
Clofarabine—Gastrointestinal pain—Etoposide—uterine cancer	8.69e-05	0.000802	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—uterine cancer	8.64e-05	0.000797	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—uterine cancer	8.64e-05	0.000797	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	8.56e-05	0.00079	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	8.52e-05	0.0013	CbGpPWpGaD
Clofarabine—Renal failure—Doxorubicin—uterine cancer	8.49e-05	0.000784	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—uterine cancer	8.47e-05	0.000782	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—uterine cancer	8.42e-05	0.000777	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—uterine cancer	8.42e-05	0.000777	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—uterine cancer	8.42e-05	0.000777	CcSEcCtD
Clofarabine—Abdominal pain—Etoposide—uterine cancer	8.4e-05	0.000775	CcSEcCtD
Clofarabine—Body temperature increased—Etoposide—uterine cancer	8.4e-05	0.000775	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—uterine cancer	8.38e-05	0.000774	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.33e-05	0.00127	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Epirubicin—uterine cancer	8.28e-05	0.000764	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—uterine cancer	8.26e-05	0.000762	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—uterine cancer	8.24e-05	0.00076	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—uterine cancer	8.23e-05	0.00076	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—YWHAE—uterine cancer	8.22e-05	0.00125	CbGpPWpGaD
Clofarabine—Urethral disorder—Epirubicin—uterine cancer	8.21e-05	0.000758	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—uterine cancer	8.17e-05	0.000754	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—uterine cancer	8.15e-05	0.000752	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	8.12e-05	0.00124	CbGpPWpGaD
Clofarabine—Sinusitis—Doxorubicin—uterine cancer	8.1e-05	0.000748	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.06e-05	0.00123	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—uterine cancer	7.97e-05	0.00121	CbGpPWpGaD
Clofarabine—Erythema multiforme—Epirubicin—uterine cancer	7.92e-05	0.000731	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	7.85e-05	0.0012	CbGpPWpGaD
Clofarabine—Hypersensitivity—Etoposide—uterine cancer	7.83e-05	0.000722	CcSEcCtD
Clofarabine—RRM1—Metabolism—RRM2—uterine cancer	7.81e-05	0.00119	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	7.8e-05	0.00119	CbGpPWpGaD
Clofarabine—Haemoglobin—Doxorubicin—uterine cancer	7.79e-05	0.000719	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—BIRC5—uterine cancer	7.79e-05	0.00119	CbGpPWpGaD
Clofarabine—Cardiac disorder—Epirubicin—uterine cancer	7.78e-05	0.000718	CcSEcCtD
Clofarabine—Flushing—Epirubicin—uterine cancer	7.78e-05	0.000718	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—uterine cancer	7.75e-05	0.000716	CcSEcCtD
Clofarabine—RRM2—Metabolism—POLD1—uterine cancer	7.72e-05	0.00118	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	7.69e-05	0.00117	CbGpPWpGaD
Clofarabine—Urinary tract disorder—Doxorubicin—uterine cancer	7.66e-05	0.000707	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—uterine cancer	7.64e-05	0.000705	CcSEcCtD
Clofarabine—Asthenia—Etoposide—uterine cancer	7.62e-05	0.000703	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—uterine cancer	7.62e-05	0.000703	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—uterine cancer	7.6e-05	0.000702	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—uterine cancer	7.6e-05	0.000702	CcSEcCtD
Clofarabine—RRM1—Metabolism—DCN—uterine cancer	7.58e-05	0.00116	CbGpPWpGaD
Clofarabine—Immune system disorder—Epirubicin—uterine cancer	7.57e-05	0.000699	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—uterine cancer	7.55e-05	0.000697	CcSEcCtD
Clofarabine—Chills—Epirubicin—uterine cancer	7.52e-05	0.000694	CcSEcCtD
Clofarabine—Pruritus—Etoposide—uterine cancer	7.51e-05	0.000694	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—uterine cancer	7.41e-05	0.000684	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—uterine cancer	7.34e-05	0.000678	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—uterine cancer	7.33e-05	0.000677	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—uterine cancer	7.3e-05	0.000673	CcSEcCtD
Clofarabine—Erythema—Epirubicin—uterine cancer	7.3e-05	0.000673	CcSEcCtD
Clofarabine—Diarrhoea—Etoposide—uterine cancer	7.27e-05	0.000671	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	7.23e-05	0.0011	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKR1C1—uterine cancer	7.22e-05	0.0011	CbGpPWpGaD
Clofarabine—DCK—Metabolism—POLD1—uterine cancer	7.21e-05	0.0011	CbGpPWpGaD
Clofarabine—Flushing—Doxorubicin—uterine cancer	7.2e-05	0.000664	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—uterine cancer	7.2e-05	0.000664	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP11A1—uterine cancer	7.14e-05	0.00109	CbGpPWpGaD
Clofarabine—Back pain—Epirubicin—uterine cancer	7.06e-05	0.000651	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—uterine cancer	7.04e-05	0.000649	CcSEcCtD
Clofarabine—Dizziness—Etoposide—uterine cancer	7.02e-05	0.000648	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—uterine cancer	7e-05	0.000646	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—uterine cancer	6.99e-05	0.000645	CcSEcCtD
Clofarabine—Chills—Doxorubicin—uterine cancer	6.96e-05	0.000642	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	6.91e-05	0.00105	CbGpPWpGaD
Clofarabine—Alopecia—Doxorubicin—uterine cancer	6.85e-05	0.000632	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	6.83e-05	0.00104	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.81e-05	0.00104	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—uterine cancer	6.79e-05	0.000627	CcSEcCtD
Clofarabine—Vomiting—Etoposide—uterine cancer	6.75e-05	0.000623	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—uterine cancer	6.75e-05	0.000623	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—uterine cancer	6.75e-05	0.000623	CcSEcCtD
Clofarabine—RRM1—Metabolism—AKR1C3—uterine cancer	6.75e-05	0.00103	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKR1C1—uterine cancer	6.74e-05	0.00103	CbGpPWpGaD
Clofarabine—Anaemia—Epirubicin—uterine cancer	6.74e-05	0.000622	CcSEcCtD
Clofarabine—Agitation—Epirubicin—uterine cancer	6.7e-05	0.000619	CcSEcCtD
Clofarabine—Rash—Etoposide—uterine cancer	6.7e-05	0.000618	CcSEcCtD
Clofarabine—Dermatitis—Etoposide—uterine cancer	6.69e-05	0.000618	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	6.65e-05	0.00101	CbGpPWpGaD
Clofarabine—Headache—Etoposide—uterine cancer	6.65e-05	0.000614	CcSEcCtD
Clofarabine—Leukopenia—Epirubicin—uterine cancer	6.53e-05	0.000603	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—uterine cancer	6.53e-05	0.000603	CcSEcCtD
Clofarabine—Cough—Epirubicin—uterine cancer	6.37e-05	0.000588	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	6.35e-05	0.000967	CbGpPWpGaD
Clofarabine—Nausea—Etoposide—uterine cancer	6.31e-05	0.000582	CcSEcCtD
Clofarabine—Hypertension—Epirubicin—uterine cancer	6.3e-05	0.000581	CcSEcCtD
Clofarabine—RRM2—Metabolism—DCN—uterine cancer	6.24e-05	0.000951	CbGpPWpGaD
Clofarabine—Anaemia—Doxorubicin—uterine cancer	6.24e-05	0.000576	CcSEcCtD
Clofarabine—Myalgia—Epirubicin—uterine cancer	6.21e-05	0.000573	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—uterine cancer	6.21e-05	0.000573	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—uterine cancer	6.2e-05	0.000573	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—uterine cancer	6.19e-05	0.000571	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN2B—uterine cancer	6.18e-05	0.000941	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.17e-05	0.000569	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—uterine cancer	6.04e-05	0.000558	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	6.01e-05	0.000916	CbGpPWpGaD
Clofarabine—DCK—Metabolism—RRM2—uterine cancer	6.01e-05	0.000916	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	5.96e-05	0.000908	CbGpPWpGaD
Clofarabine—Oedema—Epirubicin—uterine cancer	5.95e-05	0.00055	CcSEcCtD
Clofarabine—Infection—Epirubicin—uterine cancer	5.91e-05	0.000546	CcSEcCtD
Clofarabine—Cough—Doxorubicin—uterine cancer	5.89e-05	0.000544	CcSEcCtD
Clofarabine—RRM2—Metabolism—CYP11A1—uterine cancer	5.88e-05	0.000896	CbGpPWpGaD
Clofarabine—Nervous system disorder—Epirubicin—uterine cancer	5.84e-05	0.000539	CcSEcCtD
Clofarabine—DCK—Metabolism—DCN—uterine cancer	5.83e-05	0.000889	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Epirubicin—uterine cancer	5.83e-05	0.000538	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—uterine cancer	5.83e-05	0.000538	CcSEcCtD
Clofarabine—Tachycardia—Epirubicin—uterine cancer	5.81e-05	0.000536	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—uterine cancer	5.78e-05	0.000534	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	5.78e-05	0.00088	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—uterine cancer	5.76e-05	0.000531	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—uterine cancer	5.75e-05	0.00053	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—uterine cancer	5.75e-05	0.00053	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—uterine cancer	5.73e-05	0.000529	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.71e-05	0.000527	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—uterine cancer	5.68e-05	0.000524	CcSEcCtD
Clofarabine—Hypotension—Epirubicin—uterine cancer	5.56e-05	0.000514	CcSEcCtD
Clofarabine—RRM2—Metabolism—AKR1C3—uterine cancer	5.56e-05	0.000846	CbGpPWpGaD
Clofarabine—Oedema—Doxorubicin—uterine cancer	5.51e-05	0.000508	CcSEcCtD
Clofarabine—DCK—Metabolism—CYP11A1—uterine cancer	5.5e-05	0.000838	CbGpPWpGaD
Clofarabine—Infection—Doxorubicin—uterine cancer	5.47e-05	0.000505	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.42e-05	0.000501	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—uterine cancer	5.4e-05	0.000499	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—uterine cancer	5.39e-05	0.000498	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—uterine cancer	5.38e-05	0.000496	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—uterine cancer	5.35e-05	0.000494	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—uterine cancer	5.35e-05	0.000493	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BIRC5—uterine cancer	5.33e-05	0.000812	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—uterine cancer	5.33e-05	0.000492	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—uterine cancer	5.31e-05	0.00049	CcSEcCtD
Clofarabine—Somnolence—Epirubicin—uterine cancer	5.29e-05	0.000489	CcSEcCtD
Clofarabine—RRM1—Metabolism—CYP19A1—uterine cancer	5.26e-05	0.000801	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—STK11—uterine cancer	5.26e-05	0.000801	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—uterine cancer	5.25e-05	0.000485	CcSEcCtD
Clofarabine—DCK—Metabolism—AKR1C3—uterine cancer	5.19e-05	0.000791	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—uterine cancer	5.18e-05	0.000478	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2A—uterine cancer	5.16e-05	0.000787	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—uterine cancer	5.15e-05	0.000475	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—uterine cancer	5.14e-05	0.000474	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—uterine cancer	5.13e-05	0.000474	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	5.12e-05	0.000779	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	5.11e-05	0.000779	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—uterine cancer	5.09e-05	0.00047	CcSEcCtD
Clofarabine—ABCG2—Metabolism—SRD5A2—uterine cancer	5.09e-05	0.000775	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NDUFB11—uterine cancer	5.09e-05	0.000775	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.02e-05	0.000463	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—uterine cancer	4.95e-05	0.000457	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—uterine cancer	4.91e-05	0.000453	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.91e-05	0.000748	CbGpPWpGaD
Clofarabine—Feeling abnormal—Epirubicin—uterine cancer	4.91e-05	0.000453	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—uterine cancer	4.9e-05	0.000452	CcSEcCtD
Clofarabine—Gastrointestinal pain—Epirubicin—uterine cancer	4.87e-05	0.000449	CcSEcCtD
Clofarabine—Decreased appetite—Doxorubicin—uterine cancer	4.79e-05	0.000442	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.76e-05	0.000439	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—uterine cancer	4.75e-05	0.000438	CcSEcCtD
Clofarabine—Pain—Doxorubicin—uterine cancer	4.71e-05	0.000435	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—uterine cancer	4.71e-05	0.000434	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—uterine cancer	4.71e-05	0.000434	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.69e-05	0.000715	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—uterine cancer	4.57e-05	0.000697	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.54e-05	0.000692	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—uterine cancer	4.54e-05	0.000419	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—uterine cancer	4.5e-05	0.000416	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—EP300—uterine cancer	4.49e-05	0.000684	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—uterine cancer	4.39e-05	0.000405	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—uterine cancer	4.35e-05	0.000402	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—uterine cancer	4.35e-05	0.000402	CcSEcCtD
Clofarabine—RRM2—Metabolism—STK11—uterine cancer	4.33e-05	0.000659	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP19A1—uterine cancer	4.33e-05	0.000659	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—uterine cancer	4.27e-05	0.000394	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—uterine cancer	4.21e-05	0.000389	CcSEcCtD
Clofarabine—Diarrhoea—Epirubicin—uterine cancer	4.07e-05	0.000376	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—uterine cancer	4.06e-05	0.000375	CcSEcCtD
Clofarabine—DCK—Metabolism—STK11—uterine cancer	4.04e-05	0.000616	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP19A1—uterine cancer	4.04e-05	0.000616	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—EP300—uterine cancer	4.02e-05	0.000612	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—uterine cancer	3.95e-05	0.000365	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	3.95e-05	0.000602	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—uterine cancer	3.95e-05	0.000602	CbGpPWpGaD
Clofarabine—Dizziness—Epirubicin—uterine cancer	3.94e-05	0.000363	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—uterine cancer	3.9e-05	0.00036	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.84e-05	0.000584	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—uterine cancer	3.79e-05	0.000349	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—uterine cancer	3.77e-05	0.000348	CcSEcCtD
Clofarabine—Rash—Epirubicin—uterine cancer	3.75e-05	0.000347	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—uterine cancer	3.75e-05	0.000346	CcSEcCtD
Clofarabine—Headache—Epirubicin—uterine cancer	3.73e-05	0.000344	CcSEcCtD
Clofarabine—ABCG2—Metabolism—AKR1B1—uterine cancer	3.68e-05	0.00056	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STAR—uterine cancer	3.68e-05	0.00056	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—uterine cancer	3.64e-05	0.000336	CcSEcCtD
Clofarabine—Nausea—Epirubicin—uterine cancer	3.54e-05	0.000326	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN2A—uterine cancer	3.53e-05	0.000538	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—uterine cancer	3.5e-05	0.000323	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	3.5e-05	0.000533	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—uterine cancer	3.47e-05	0.000321	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—uterine cancer	3.47e-05	0.00032	CcSEcCtD
Clofarabine—Headache—Doxorubicin—uterine cancer	3.45e-05	0.000319	CcSEcCtD
Clofarabine—Nausea—Doxorubicin—uterine cancer	3.27e-05	0.000302	CcSEcCtD
Clofarabine—RRM2—Metabolism—MTHFR—uterine cancer	3.25e-05	0.000496	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—uterine cancer	3.13e-05	0.000477	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—EP300—uterine cancer	3.07e-05	0.000468	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—uterine cancer	3.04e-05	0.000463	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—POLD1—uterine cancer	2.89e-05	0.00044	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—uterine cancer	2.87e-05	0.000438	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—EP300—uterine cancer	2.75e-05	0.000419	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C1—uterine cancer	2.7e-05	0.000411	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—RRM2—uterine cancer	2.41e-05	0.000367	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DCN—uterine cancer	2.34e-05	0.000356	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP11A1—uterine cancer	2.2e-05	0.000335	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—uterine cancer	2.2e-05	0.000335	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—EP300—uterine cancer	2.1e-05	0.000319	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKR1C3—uterine cancer	2.08e-05	0.000317	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—uterine cancer	1.97e-05	0.0003	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—uterine cancer	1.81e-05	0.000276	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—EP300—uterine cancer	1.73e-05	0.000263	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—uterine cancer	1.69e-05	0.000258	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STK11—uterine cancer	1.62e-05	0.000247	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP19A1—uterine cancer	1.62e-05	0.000247	CbGpPWpGaD
Clofarabine—DCK—Metabolism—EP300—uterine cancer	1.61e-05	0.000246	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—uterine cancer	1.55e-05	0.000236	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—uterine cancer	1.28e-05	0.000194	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—uterine cancer	1.27e-05	0.000193	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—uterine cancer	1.22e-05	0.000185	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—uterine cancer	1.19e-05	0.000182	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—uterine cancer	1.04e-05	0.000159	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—uterine cancer	9.74e-06	0.000148	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—uterine cancer	6.77e-06	0.000103	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EP300—uterine cancer	6.45e-06	9.83e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—uterine cancer	4.77e-06	7.27e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—uterine cancer	3.9e-06	5.94e-05	CbGpPWpGaD
